SUPPRESSION OF MANGANESE SUPEROXIDE DISMUTASE ACTIVITY IN ROTENONE-TREATED HUMAN GLIOBLASTOMA T98G CELLS REDUCES CELL VIABILITY

Authors

  • Septelia Inawati Wanandi Department of Biochemistry & Molecular Biology Faculty of Medicine Universitas Indonesia
  • Novi Silvia Hardiany Department of Biochemistry & Molecular Biology Faculty of Medicine Universitas Indonesia
  • Nurjati Chairani Siregar Department of Anatomic Pathology, Faculty of Medicine Universitas Indonesia
  • Mohamad Sadikin Department of Biochemistry & Molecular Biology Faculty of Medicine Universitas Indonesia

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i1.19777

Keywords:

Cell viability, Glioblastoma multiforme, Manganese superoxide dismutase, Rotenone

Abstract

 

 Objective: Glioma is the most common human primary brain tumor which is highly resistant to oxidative stress-based anticancer. The aim of this study was to analyze the effect of rotenone-induced reactive oxygen species (ROS) on the modulation of manganese superoxide dismutase (MnSOD) expression and cell viability in human glioblastoma (GBM) T98G cells.

Methods: In this in vitro experimental study, T98G cells were treated with high-dose rotenone (0.5, 5, and 50 μM, respectively). Following rotenone treatment and intracellular ROS, both peroxide and superoxide radicals were determined. Moreover, we analyzed MnSOD mRNA expression, protein, and specific activity, as well as cell survival including viability, proliferation, apoptosis, and mitochondrial structure.

Results: High-dose rotenone treatment of T98G cells significantly increased intracellular ROS and MnSOD mRNA, but its protein and specific activity definitely decreased. The treatment also led to a reduction of cell viability, enhancement of apoptosis, and disruption of mitochondrial integrity.

Conclusion: Overproduction of ROS in rotenone-treated human GBM T98G cells could suppress the MnSOD protein level and activity even though mRNA synthesis has been increased. This modulation led to reduced survival of T98G cells through induction of cell death rather than inhibition of cell proliferation.

Downloads

Download data is not yet available.

References

Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006;2:494-503.

Goldlust SA, Turner GM, Goren JF, Gruber ML. Glioblastoma multiforme: Multidisciplinary care and advances in therapy. Hosp Physician 2008;39:9-22.

Maji P, Chatterjee R, Choudhury BP, Chatterji U, Ganguly J. Enhanced p53-dependent growth inhibition of human glioblastoma cells by combinatorial treatment of temozolomide and novel purified natural carbohydrate of Pleurotus florida. Int J Pharm Pharm Sci 2017;9:189-93.

Khan YY, Suvarna V. Liposomes containing phytochemicals for cancer treatment-an update. Int J Curr Pharm Res 2017;9:20-4.

Krakstad C, Chekenya M. Survival signalling and apoptosis resistance in GBM: Opportunities for targeted therapeutics. Mol Cancer 2010;9:135.

Lee HC, Kim DW, Jung KY, Park IC, Park MJ, Kim MS, et al. Increased expression of antioxidant enzymes in radioresistant variant from U251 human glioblastoma cell line. Int J Mol Med 2004;13:883-7.

Hardiany NS, Mulyawan W, Wanandi SI. Correlation between oxidative stress and tumor grade in glioma cells from patients in Jakarta. Med J Indones 2012;21:122-7.

Zhong W, Oberley LW, Oberley TD, St Clair DK. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese SOD. Oncogene 1997;14:481-90.

Venkataraman S, Jiang X, Weydert C, Zhang Y, Zhang HJ, Goswami PC, et al. Manganese SOD overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 2005;24:77-89.

Mancini A, Borrelli A, Schiattarella A, Fasano S, Occhiello A, Pica A, et al. Tumor suppressive activity of a variant isoform of manganese SOD released by a human liposarcoma cell line. Int J Cancer 2006;119:932-43.

Järvelä S, Bragge H, Paunu N, Järvelä T, Paljärvi L, Kalimo H, et al. Antioxidant enzymes in oligodendroglial brain tumors: Association with proliferation, apoptotic activity and survival. J Neurooncol 2006;77:131-40.

Hu Y, Rosen DG, Zhou Y, Feng L, Yang G, Liu J, et al. Mitochondrial manganese-SOD expression in ovarian cancer: Role in cell proliferation and response to oxidative stress. J Biol Chem 2005;280:39485-92.

Siddiqui MA, Saquib Q, Ahamed M, Ahmad J, Al-Khedhairy AA, Abou-Tarboush FM, et al. Effect of trans-resveratrol on rotenone-induced cytotoxicity in human breast adenocarcinoma cells. Toxicol Int 2011;18:105-10.

Li J, Spletter ML, Johnson DA, Wright LS, Svendsen CN, Johnson JA. Rotenone-induced caspase 9/3-independent and -dependent cell death in undifferentiated and differentiated human neural stem cells. J Neurochem 2005;92:462-76.

Fang N, Casida JE. Anticancer action of cubé insecticide: Correlation for rotenoid constituents between inhibition of NADH:ubiquinone oxidoreductase and induced ornithine decarboxylase activities. Proc Natl Acad Sci U S A 1998;95:3380-4.

Ansari R, Perween Q, Kumar G, Jayanand, Rai DV. Effect of butylated hydroxyanisole on hydrogen peroxide induced oxidative stress on cerebral glioma cell line. Asian J Pharm Clin Res 2014;7 Suppl 1:177-80.

Shim HY, Park JH, Paik HD, Nah SY, Kim DS, Han YS. Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/ JNK1/2-c-Jun activation. Mol Cells 2007;24:95-104.

Viola G, Salvador A, Vedaldi D, Fortunato E, Disarò S, Basso G, et al. Induction of apoptosis by photoexcited tetracyclic compounds derivatives of benzo[b]thiophenes and pyridines. J Photochem Photobiol B 2006;82:105-16.

Barathi S, Vardhini S, Chitra P, Arulselvi PI. Cytotoxic effect of juglone on human peripheral blood lymphocytes. Asian J Pharm Clin Res 2013;6:178-86.

Hardiany NS, Sadikin M, Wanandi SI. Gene expression of manganese SOD (MnSOD) in human glioma cells. Med J Indones 2010;19:21-5.

Epperly M, Bray J, Kraeger S, Zwacka R, Engelhardt J, Travis E, et al. Prevention of late effects of irradiation lung damage by manganese SOD gene therapy. Gene Ther 1998;5:196-208.

Davies HA. General preparation of material and staining of sections. In: Electron Microscopy Methods and Protocols Methods in Molecular Biology. Totowa: Humana Press; 2007. p. 1-11.

Ahmadi FA, Linseman DA, Grammatopoulos TN, Jones SM, Bouchard RJ, Freed CR, et al. The pesticide rotenone induces caspase- 3-mediated apoptosis in ventral mesencephalic dopaminergic neurons. J Neurochem 2003;87:914-21.

Jin J, Davis J, Zhu D, Kashima DT, Leroueil M, Pan C, et al. Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells. BMC Neurosci 2007;8:67.

Rohini D, Vijayalakshmi K. Sesamol antagonizes rotenone induced cell death in SH-SY5Y neuronal cells. Int J Pharm Pharm Sci 2016;8:72-7.

Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial ROS production. J Biol Chem 2003;278:8516-25.

Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990;265:659-65.

Bai L, Wang J, Yin XM, Dong Z. Analysis of apoptosis. In: Essentials of Apoptosis. Totowa, New Jersey: Humana Press; 2003. p. 239-50.

Gonçalves AP, Máximo V, Lima J, Singh KK, Soares P, Videira A. Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone. Biochim Biophys Acta 2011;1813:492-9.

Wang XJ, Xu JX. Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurosci Lett 2005;376:127-32.

Higuchi Y. Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem Pharmacol 2003;66:1527-35.

Krysko DV, Vanden Berghe T, D’Herde K, Vandenabeele P. Apoptosis and necrosis: Detection, discrimination and phagocytosis. Methods 2008;44:205-21.

Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H, et al. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: Possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene 1996;12:2045-50.

Halliwell B, Gutteridge JM, editors. Cellular responses to oxidative stress: Adaptation, damage, repair, senescence and death. In: Free Radicals in Biology and Medicine. 4th ed. New York: Oxford University Press; 2007. p. 187-267.

Ria F, Landriscina M, Remiddi F, Rosselli R, Iacoangeli M, Scerrati M, et al. The level of manganese SOD content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications. Br J Cancer 2001;84:529-34.

Kim JJ, Chae SW, Hur GC, Cho SJ, Kim MK, Choi J, et al. Manganese SOD expression correlates with a poor prognosis in gastric cancer. Pathobiology 2002-2003;70:353-60.

Kattan Z, Minig V, Leroy P, Dauça M, Becuwe P. Role of manganese SOD on growth and invasive properties of human estrogen-independent breast cancer cells. Breast Cancer Res Treat 2008;108:203-15.

Nelson KK, Ranganathan AC, Mansouri J, Rodriguez AM, Providence KM, Rutter JL, et al. Elevated sod2 activity augments matrix metalloproteinase expression: Evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res 2003;9:424-32.

Reddy SP, Britto R, Vinnakota K, Aparna H, Sreepathi HK, Thota B, et al. Novel glioblastoma multiforme markers with diagnostic and prognostic value identified through transcriptome analysis. Clin Cancer Res 2008;14:2978-87.

Hai HU, Li LM, Li DX, Bin FY, Yu Z, Ming SX, et al. Up-regulated manganese SOD expression increase apoptosis resistance in human esophageal squamous cell carcinomas. Chin Med J 2007;120:2092-8.

Wong KY, Yeung BH, Wong AS. Antiapoptotic effects of mitochondrial manganese SOD in ovarian cancer cells. HKMJ Suppl 2006;12 Suppl 4:S170.

Kuninaka S, Ichinose Y, Koja K, Toh Y. Suppression of manganese SOD augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. Br J Cancer 2000;83:928-34.

Ghazalpour A, Bennett B, Petyuk VA, Orozco L, Hagopian R, Mungrue IN, et al. Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet 2011;7:e1001393.

Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 2012;13:227-32.

Hardiany NS, Sadikin M, Siregar N, Wanandi SI. The suppression of manganese SOD decreased the survival of human glioblastoma multiforme T98G cells. Med J Indones 2017;26:19-25.

Published

01-01-2018

How to Cite

Wanandi, S. I., N. S. Hardiany, N. C. Siregar, and M. Sadikin. “SUPPRESSION OF MANGANESE SUPEROXIDE DISMUTASE ACTIVITY IN ROTENONE-TREATED HUMAN GLIOBLASTOMA T98G CELLS REDUCES CELL VIABILITY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 1, Jan. 2018, pp. 48-54, doi:10.22159/ajpcr.2018.v11i1.19777.

Issue

Section

Original Article(s)